However, the cancer cell killing activity of DNMDP does not correlate with inhibition of PDE3A enzymatic activity, in that other potent and selective PDE3 inhibitors such as trequinsin10 do not kill cancer cells, and knockout of PDE3A from sensitive cell lines abolishes DNMDP sensitivity1,3. This evidence concerns the gene PDE3A and cancer.